Loading stock data…
$5.23-0.38 (-6.77%)
SANUWAVE Health, Inc.
SANUWAVE Health, Inc. in the Healthcare sector is trading at $5.23 with a market capitalization of $36M. The stock is currently near its 52-week low of $3.92, remaining 65.0% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.74M↑ | $9.62M↓ | $13.09M↑ | $11.45M↑ | $10.05M |
| Gross Profit | $7.42M | $7.43M↓ | $9.70M↑ | $8.93M↑ | $7.85M |
| Operating Income | -$280,000↑ | -$1.12M↓ | $615,000↓ | $1.47M↑ | $1.44M |
| Net Income | -$682,000↑ | -$1.44M↓ | $6.11M↓ | $10.32M↑ | $551,000 |
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting...